Eric K Rowinsky Selected Research

Eric K Rowinsky Research Topics

Disease

85	Neoplasms (Cancer) 02/2015 - 01/2002
16	Neutropenia 10/2011 - 05/2002
12	Colorectal Neoplasms (Colorectal Cancer) 02/2011 - 01/2002
7	Adenocarcinoma 04/2024 - 01/2003
7	Fatigue 04/2024 - 07/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2012 - 05/2002
7	Disease Progression 10/2011 - 05/2003
7	Breast Neoplasms (Breast Cancer) 06/2010 - 01/2003
7	Exanthema (Rash) 06/2010 - 08/2004
6	Thrombocytopenia (Thrombopenia) 01/2011 - 07/2003
5	Fever (Fevers) 04/2024 - 07/2002
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 07/2007
4	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2004
4	Diarrhea 12/2006 - 07/2002
3	Sarcoma (Soft Tissue Sarcoma) 06/2011 - 08/2007
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2010 - 02/2006
3	Squamous Cell Carcinoma of Head and Neck 01/2010 - 02/2006
3	Nausea 06/2009 - 07/2002
3	Vomiting 10/2006 - 07/2002
2	Asthenia 06/2010 - 10/2006
2	Mucositis 06/2010 - 04/2003
2	Hematologic Neoplasms (Hematological Malignancy) 02/2010 - 09/2007
2	Anorexia 06/2009 - 07/2002
2	Hyperbilirubinemia 10/2008 - 07/2003
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2007 - 08/2004
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2007 - 12/2004
2	Melanoma (Melanoma, Malignant) 02/2007 - 07/2002
2	Febrile Neutropenia 02/2006 - 01/2006
2	Lung Neoplasms (Lung Cancer) 12/2004 - 02/2003
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2003 - 01/2002
1	Chills 04/2024

Drug/Important Bio-Agent (IBA)

14	ErbB Receptors (EGF Receptor)IBA 02/2011 - 01/2002
10	Monoclonal AntibodiesIBA 03/2010 - 01/2003
8	Cetuximab (Erbitux)FDA Link 08/2012 - 03/2005
6	Transaminases (Aminotransferases)IBA 04/2024 - 07/2002
6	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 03/2012 - 02/2003
5	Cisplatin (Platino)FDA LinkGeneric 02/2012 - 02/2003
5	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 01/2003
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010 - 07/2003
4	Gemcitabine FDA Link 04/2024 - 10/2003
4	Tyrosine Kinase InhibitorsIBA 07/2010 - 05/2002
4	TOR Serine-Threonine KinasesIBA 06/2010 - 06/2003
4	Irinotecan (Camptosar)FDA LinkGeneric 12/2008 - 08/2004
4	Sirolimus (Rapamycin)FDA Link 01/2008 - 06/2003
4	Pemetrexed (MTA)FDA Link 05/2007 - 01/2006
3	EnzymesIBA 04/2024 - 07/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 02/2007
3	Carboplatin (JM8)FDA LinkGeneric 03/2012 - 12/2006
3	TrabectedinIBA 05/2010 - 01/2002
3	troxacitabineIBA 12/2009 - 01/2002
3	LigandsIBA 12/2005 - 01/2004
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2005 - 02/2003
3	CamptothecinIBA 11/2005 - 01/2003
3	exatecan (DX 8951f)IBA 08/2005 - 07/2003
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004 - 01/2003
3	PlatinumIBA 08/2004 - 05/2002
2	Bexarotene (LGD1069)FDA Link 03/2012 - 02/2012
2	NucleosidesIBA 02/2012 - 01/2002
2	Hormones (Hormone)IBA 12/2011 - 08/2004
2	cixutumumabIBA 12/2011 - 09/2007
2	Insulin-Like PeptidesIBA 12/2011 - 11/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2011 - 02/2003
2	Sorafenib (BAY 43-9006)FDA Link 06/2011 - 09/2005
2	temsirolimus FDA Link 06/2010 - 10/2006
2	Immunoglobulin G (IgG)IBA 03/2010 - 02/2010
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2010 - 02/2010
2	Cytotoxins (Cytolysins)IBA 02/2010 - 05/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2010 - 01/2002
2	Phosphotransferases (Kinase)IBA 02/2010 - 07/2003
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2010 - 09/2007
2	taxaneIBA 01/2009 - 10/2003
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2008 - 10/2006
2	Thymidylate SynthaseIBA 12/2008 - 11/2004
2	CreatinineIBA 10/2008 - 01/2006
2	Lapatinib (GW572016)FDA Link 07/2008 - 08/2007
2	AntibodiesIBA 09/2007 - 07/2004
2	tetracycline CMT-3IBA 08/2007 - 10/2004
2	VitaminsIBA 01/2007 - 02/2006
2	Growth Factor ReceptorsIBA 09/2005 - 06/2003
2	Docetaxel (Taxotere)FDA Link 11/2004 - 08/2004
2	Biomarkers (Surrogate Marker)IBA 08/2004 - 08/2004
2	Epidermal Growth Factor (EGF)IBA 08/2004 - 03/2004
2	Fluorouracil (Carac)FDA LinkGeneric 01/2004 - 04/2003
2	Farnesyltranstransferase (Farnesyltransferase)IBA 10/2003 - 10/2003
2	Trastuzumab (Herceptin)FDA Link 10/2003 - 01/2003
2	Gefitinib (Iressa)FDA Link 01/2003 - 05/2002
2	Topotecan (Hycamtin)FDA LinkGeneric 05/2002 - 01/2002
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024
1	Alkaline PhosphataseIBA 04/2024
1	130-nm albumin-bound paclitaxelIBA 04/2024
1	Alanine Transaminase (SGPT)IBA 04/2024
1	Deubiquitinating EnzymesIBA 10/2020
1	Bortezomib (Velcade)FDA Link 10/2020

Therapy/Procedure

22	Therapeutics 08/2012 - 01/2002
10	Drug Therapy (Chemotherapy) 04/2024 - 01/2003
4	Radiotherapy 01/2010 - 03/2004
2	Drug Tapering 06/2010 - 10/2006
2	Aftercare (After-Treatment) 06/2007 - 07/2003
1	Injections 04/2024